Stocks Under $10: Newcastle Investment

Richard Suttmeier |

Newcastle Investment (NCT) – ($5.56) has a Strong Buy rating according to ValuEngine with fair value at $14.03, which makes the stock 60.4% undervalued. The stock has a one-year price target at $6.72. ValuEngine Profile – “Newcastle Investment Corp invests in real estate securities and other real estate-related assets. Newcastle is organized and conducts its operations to qualify as a real estate investment trust for federal income tax purposes.”

Analysis – The daily chart for NCT shows rising momentum with the stock above its 21-day, 50-day and 200-day simple moving averages at $5.49, $5.32 and $4.50. My weekly value level is $5.33 with a quarterly risky level at $8.63.

         


Courtesy of Thomson / Reuters

 

Ticker

Company Name

Mkt Price

Fair Value

One-Year Price Target



Last 12-Mon Retn (%)

5-Yr Avg Retn (%)

P/E Ratio

NCT

NEWCASTLE INVESTMENT

5.56

14.03

6.72

-16.01

-13.46

4.96

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
NCT Newcastle Investment Corporation n/a n/a n/a 0 Trade
ASUR Asure Software Inc 13.75 0.08 0.59 182,313 Trade

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…